
SF Healthcare Week: Biohaven's Chairman & CEO Vlad Coric shares updates on the company's pipeline in immunology, obesity, and epilepsy
BiotechTV - News
00:00
Obesity pivotal trial and future combinations
Vlad confirms the obesity pivotal trial is underway and says 2026 data will guide monotherapy or combination strategies.
Play episode from 08:47
Transcript


